Platform offers patient-reported outcomes at point of care for cancer providers

Laura Pedulli | | Health Exec | EMR/EHR

Flatiron Health and Vector Oncology are offering an EMR platform that enables oncology providers to gather and view patient-reported symptoms at the point of care.

Oncology's Patient Care Monitor, integrated with cloud-based OncoEMR, is designed to address oncology treatment, disease and business management. It collects data from patients at the point of care and between visits regarding 86 physical symptoms across treatment side effects, impairment, acute distress and despair and depression, according to a release.

The product aims to give oncology care providers additional insights to support quality of life and alleviate symptom burden for cancer patients. Flatiron Health and Vector Oncology also plan to collaborate on studies involving health outcomes and economic endpoints in support of clinical research efforts and real-world evidence generation.

 

"The integration of Flatiron's OncoEMR with our Patient Care Monitor will create an unmatched source of real world clinical and patient reported outcomes intelligence to improve the quality of cancer care and demonstrate the effectiveness and value of treatments," said Mike Choukas, chief executive officer of Vector Oncology, in a statement.

Laura Pedulli

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”